Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de China Shineway Pharmaceutical Group Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), China Shineway Pharmaceutical Group Ltd tiene un total de activos de $10,041, una ganancia neta profit de $840

Question 2

¿Cuáles son los ratios financieros clave para CSWYY?

Accepted Answer

El ratio corriente de China Shineway Pharmaceutical Group Ltd es 3.9, el margen neto es 22.23, las ventas por acción son $5.

Question 3

¿Cómo se desglosan los ingresos de China Shineway Pharmaceutical Group Ltd por segmento o geografía?

Accepted Answer

China Shineway Pharmaceutical Group Ltd largest revenue segment is Injections, at a revenue of 1,374,777,459 in the most earnings release.For geography, China including Hong Kong is the primary market for China Shineway Pharmaceutical Group Ltd, at a revenue of 4,096,244,475.

Question 4

¿Es rentable China Shineway Pharmaceutical Group Ltd?

Accepted Answer

yes, según los últimos estados financieros, China Shineway Pharmaceutical Group Ltd tiene una ganancia neta profit de $840

Question 5

¿Tiene China Shineway Pharmaceutical Group Ltd alguna deuda?

Accepted Answer

yes, China Shineway Pharmaceutical Group Ltd tiene una deuda de 2,574

Question 6

¿Cuántas acciones en circulación tiene China Shineway Pharmaceutical Group Ltd?

Accepted Answer

China Shineway Pharmaceutical Group Ltd tiene un total de acciones en circulación de 827

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,344	3,778	4,516	3,950	3,223	2,655
Revenue Growth (YoY)	-20%	-16%	14%	23%	21%	-2%
Cost of Revenue	890	946	1,122	1,012	813	667
Gross Profit	2,453	2,831	3,394	2,938	2,410	1,987
Selling, General & Admin	1,700	1,895	2,313	2,107	1,763	1,458
Research & Development	106	100	110	117	112	99
Operating Expenses	1,638	1,817	2,260	2,111	1,773	1,472
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1,058	1,145	1,240	917	720	395
Income Tax Expense	230	305	270	194	163	99
Net Income	828	840	969	722	556	295
Net Income Growth	-25%	-13%	34%	30%	88%	-41%
Shares Outstanding (Diluted)	755.4	755.4	755.4	755.4	755.14	756.74
Shares Change (YoY)	0%	0%	0%	0%	0%	-3%
EPS (Diluted)	1.09	1.11	1.28	0.95	0.73	0.38
EPS Growth	-25%	-13%	34%	30%	89%	-39%
Free Cash Flow	799	823	788	980	609	572
Free Cash Flow Per Share	1.05	1.08	1.04	1.29	0.8	0.75
Gross Margin	73.35%	74.93%	75.15%	74.37%	74.77%	74.83%
Operating Margin	24.34%	26.81%	25.08%	20.91%	19.73%	19.39%
Profit Margin	24.76%	22.23%	21.45%	18.27%	17.25%	11.11%
Free Cash Flow Margin	23.89%	21.78%	17.44%	24.81%	18.89%	21.54%
EBITDA	--	1,081	1,310	1,011	818	723
EBITDA Margin	--	28.61%	29%	25.59%	25.38%	27.23%
D&A For EBITDA	--	68	177	185	182	208
EBIT	814	1,013	1,133	826	636	515
EBIT Margin	24.34%	26.81%	25.08%	20.91%	19.73%	19.39%
Effective Tax Rate	21.73%	26.63%	21.77%	21.15%	22.63%	25.06%

China Shineway Pharmaceutical Group Ltd (CSWYY) Price

CSWYY Stock Price Chart

CSWYY Income

Follow-Up Questions